Browse

Evaluation of the anti-inflammatory and atopic dermatitis-mitigating effects of BSASM, a multicompound preparation

DC Field Value Language
dc.contributor.authorLee, J.-
dc.contributor.authorJung, E.-
dc.contributor.authorPark, B.-
dc.contributor.authorJung, K.-
dc.contributor.authorPark, J.-
dc.contributor.authorKim, K.-
dc.contributor.authorKim, K. H.-
dc.contributor.authorPark, D.-
dc.date.accessioned2009-12-24T11:23:14Z-
dc.date.available2009-12-24T11:23:14Z-
dc.date.issued2004-12-14-
dc.identifier.citationJ Ethnopharmacol. 2005 Jan 4;96(1-2):211-9.en
dc.identifier.issn0378-8741 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15588673-
dc.identifier.urihttp://hdl.handle.net/10371/22620-
dc.description.abstractFor effective management of atopic dermatitis (AD), it is important to introduce a therapeutic agent, which although having the fewest side effects, has the greatest anti-inflammatory effect. In the course of screening anti-inflammatory agents, we obtained BSASM, a mixture of several plant extracts. This study was designed to investigate the AD-mitigating effect of BSASM in patients, as well as its anti-inflammatory and immunomodulatory effects in an in vitro experiment. The anti-inflammatory effects of BSASM were evaluated by the level of production of proinflammatory cytokines. Clinical evaluation was also done using eczema area severity index (EASI) score in AD patients. BSASM inhibited LPS-induced activation of NF-kappaB promoter. In addition, LPS-induced an increase of IL-8, and the TNF-alpha production in THP-1 cells was also inhibited. These results suggest that BSASM has an anti-inflammatory activity. A clinical study in patients with AD showed that BSASM induced a reduction of EASI score, degree of pruritus, and TEWL on both the antecubital fossa and abdomen. Besides, BSASM had no irritative or allergic effects. Based on these results, we conclude that BSASM has anti-inflammatory and AD-mitigating effects.en
dc.language.isoenen
dc.publisherElsevieren
dc.subjectAdjuvants, Immunologic/pharmacology/*therapeutic use/toxicityen
dc.subjectAdolescenten
dc.subjectAnti-Inflammatory Agents/pharmacology/*therapeutic use/toxicityen
dc.subjectCell Lineen
dc.subjectChilden
dc.subjectCytokines/biosynthesisen
dc.subjectDermatitis, Atopic/*drug therapyen
dc.subjectDrugs, Chinese Herbal/pharmacology/therapeutic use/toxicityen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectInterleukin-2/biosynthesisen
dc.subjectInterleukin-8/biosynthesisen
dc.subjectLipopolysaccharides/pharmacologyen
dc.subjectMaleen
dc.subjectNF-kappa B/metabolismen
dc.subject*Phytotherapyen
dc.subjectPlant Extracts/pharmacology/*therapeutic use/toxicityen
dc.subjectTime Factorsen
dc.subjectTumor Necrosis Factor-alpha/biosynthesisen
dc.titleEvaluation of the anti-inflammatory and atopic dermatitis-mitigating effects of BSASM, a multicompound preparationen
dc.typeArticleen
dc.contributor.AlternativeAuthor이종성-
dc.contributor.AlternativeAuthor정은선-
dc.contributor.AlternativeAuthor박병화-
dc.contributor.AlternativeAuthor정광선-
dc.contributor.AlternativeAuthor박준호-
dc.contributor.AlternativeAuthor김국현-
dc.contributor.AlternativeAuthor김규한-
dc.contributor.AlternativeAuthor박덕훈-
dc.identifier.doi10.1016/j.jep.2004.09.012-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Immunology (면역학전공)Journal Papers (저널논문_면역학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse